Suppr超能文献

成人低级别胶质瘤患者术后五年内肿瘤进展的预测因素

Predicting factors of tumor progression in adult patients with low-grade glioma within five years after surgery.

作者信息

Li Xuezheng, Li Ruimin, Ren Hongbo, Liu He, Liu Hongfeng

机构信息

Department of Clinical Examination, Handan Central Hospital of Hebei Province, Handan, China.

Department of Neurosurgery, Handan Central Hospital of Hebei Province, Handan, China.

出版信息

Transl Cancer Res. 2021 Apr;10(4):1907-1915. doi: 10.21037/tcr-21-589.

Abstract

BACKGROUND

Glioma is the most common primary intracranial tumor with the worst prognosis whose 5-year mortality rate is second only to pancreatic cancer and lung cancer among systemic tumors. WHO divides gliomas into grades I to IV, with grades I and II as low grades. Low-grade gliomas tend to occur in people between the ages of 30 and 40, who usually have the characteristics of well-differentiated, slow growth, and low invasiveness. Timely diagnosis and surgery are the main treatment strategies for low-grade gliomas. The current ideal treatment represents the MST reaching average seven years. However, many patients relapse with adverse outcomes. It's important to identify high-risk patients by predicting factors in adult patients with low-grade glioma.

METHODS

A total of 287 patients who were treated in our hospital from February 2011 to May 2015 were included in the final analysis according to the inclusion and exclusion criteria. The patients were divided into progression-free groups and progression groups according to the results of 5-year follow-up after surgery by information like patients' baseline data, surgical data, postoperative follow-up data. The ROC was used to analyze the greatest quantitative treatment boundary value and distinguish high and low risk. Kaplan-Meier survival curve was used to analyze risk factors' predictive value for patients' postoperative results.

RESULTS

The results of 5-year follow-up showed 122 cases (42.5%) had no progression (progression-free group), 165 cases (57.5%) had progression (progression group). Univariate and multivariate analysis showed that age older than 50 (OR =1.42, P=0.013), partial resection of tumor (OR =1.86, P=0.027), tumor diameter larger than 5 cm (OR =1.85, P=0.022) and long-term statins treatment before surgery (OR =0.36, P=0.036) were closely associated with tumor progression. The Kaplan-Meier survival curve showed patients aged older than 50, partial resection of the tumor, a tumor diameter larger than 5 cm whose results were poor, while long-term statins treatment before surgery had a better prognosis within the 5-year follow-up.

CONCLUSIONS

Patients aged older than 50, partial resection of the tumor, tumor diameter larger than 5 cm and long-term statins treatment before surgery were closely related to the prognosis after surgery.

摘要

背景

胶质瘤是最常见的原发性颅内肿瘤,预后最差,其5年死亡率在全身肿瘤中仅次于胰腺癌和肺癌。世界卫生组织将胶质瘤分为I至IV级,I级和II级为低级别。低级别胶质瘤倾向于发生在30至40岁的人群中,通常具有分化良好、生长缓慢和侵袭性低的特点。及时诊断和手术是低级别胶质瘤的主要治疗策略。目前理想的治疗方法是中位生存期达到7年。然而,许多患者会复发并产生不良后果。通过预测因素识别成年低级别胶质瘤患者中的高危患者很重要。

方法

根据纳入和排除标准,对2011年2月至2015年5月在我院接受治疗的287例患者进行最终分析。根据患者的基线数据、手术数据、术后随访数据等手术5年随访结果,将患者分为无进展组和进展组。采用ROC分析最大定量治疗界值并区分高、低风险。采用Kaplan-Meier生存曲线分析危险因素对患者术后结果的预测价值。

结果

5年随访结果显示,122例(42.5%)无进展(无进展组),165例(57.5%)有进展(进展组)。单因素和多因素分析显示,年龄大于50岁(OR =1.42,P=0.013)、肿瘤部分切除(OR =1.86,P=0.027)、肿瘤直径大于5 cm(OR =1.85,P=0.022)和术前长期使用他汀类药物治疗(OR =0.36,P=0.036)与肿瘤进展密切相关。Kaplan-Meier生存曲线显示,年龄大于50岁、肿瘤部分切除、肿瘤直径大于5 cm的患者预后较差,而术前长期使用他汀类药物治疗在5年随访期内预后较好。

结论

年龄大于50岁、肿瘤部分切除、肿瘤直径大于5 cm以及术前长期使用他汀类药物治疗与术后预后密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aeb/8797588/e803f0a3a489/tcr-10-04-1907-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验